The role of nuclear factor κb in the interferon response

Journal of Interferon and Cytokine Research

Volumn 31, Issue 7, 2011, Pages 553-559

  Pfeffer, Lawrence M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR; MICRORNA; STAT PROTEIN;

ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER IMMUNOTHERAPY; CELL SURVIVAL; CYTOKINE RESPONSE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BACTERIAL INFECTIONS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, CELLULAR; INTERFERONS; NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VIRUS DISEASES;

EID: 79960115481     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0028     Document Type: Review

References (44)

1. Au PY, Yeh WC. 2007. Physiological roles and mechanisms of signaling by TRAF2 and TRAF5. Adv Exp Med Biol 597:32-47
2. Baeuerle PA. 1998. IkB-NFkB structures: at the interface of inflammation control. Cell 95:729-731. (Pubitemid 29014451)
3. Baeurele PA, Baltimore D. 1988. IkB: a specific inhibitor of NFkB transcription factor. Science 242:540-546. (Pubitemid 18263193)
4. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297.
5. Beg AA, Baltimore D. 1996. An essential role for NF-κB in preventing TNF-a-induced cell death. Science 274:782-784. (Pubitemid 26398258)
6. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M. 2004. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J 23(21):4202-4210. (Pubitemid 39546158)
7. Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029-6033. (Pubitemid 40994386)
8. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8(3):237-249. (Pubitemid 36749609)
9. Cheng CS, Feldman KE, Lee J, Verma S, Huang DB, Huynh K, Chang M, Ponomarenko JV, Sun SC, Benedict CA, Ghosh G, Hoffmann A. 2011. The specificity of innate immune responses is enforced by repression of interferon response elements by NF-{kappa}B p50. Sci Signal 4(161):ra11.
10. Clark J, Edwards S, Feber A, Flohr P, John M, Giddings I, Crossland S, Stratton MR, Wooster R, Campbell C, Cooper CS. 2003. Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene 22(8):1247-1252. (Pubitemid 36363389)
11. Deb A, Haque SJ, Mogensen T, Silverman RH, Williams BR. 2001. RNA-dependent protein kinase PKR is required for activation of NF-κ B by IFN-gamma in a STAT1-independent pathway. J Immunol 166(10):6170-6180. (Pubitemid 32440747)
12. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR. 2002. The lymphotoxinbeta receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17(4):525-535. (Pubitemid 35223540)
13. Du Z, Wei L, Murti A, Pfeffer SR, Fan M, Yang CH, Pfeffer LM. 2007. Non-conventional signal transduction by type 1 interferons: the NF-κB pathway. J Cell Biochem 102(5):1087-1094. (Pubitemid 350220030)
14. Folini M, Gandellini P, Longoni N, Profumo V, Callari M, Pennati M, Colecchia M, Supino R, Veneroni S, Salvioni R, Valdagni R, Daidone MG, Zaffaroni N. 2010. miR-21: an oncomir on strike in prostate cancer. Mol Cancer 9:12.
15. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liverspecific MicroRNA. Science 309(5740):1577-1581. (Pubitemid 41266486)
16. Karin M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441(7092):431-436. (Pubitemid 44050137)
17. Li Q, Withoff S, Verma IM. 2005. Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol 26(6):318-325.
18. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433(7027):769-773. (Pubitemid 40292988)
19. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, Cvijic H, Ullmann AK, Stadler PF, Horn F. 2007. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110(4):1330-1333. (Pubitemid 47281433)
20. Marrack P, Kappler J, Mitchell T. 1999. Type I interferons keep activated T cells alive. J Exp Med 189:521-530.
21. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. 2007. Interferon modulation of cellular micro-RNAs as an antiviral mechanism. Nature 449(7164):919-922. (Pubitemid 47598616)
22. Pfeffer LM, Kim JG, Pfeffer SR, Carrigan DJ, Baker DP, Wei L, Homayouni R. 2004. The role of NF-κB in the antiviral action of interferon and interferon-regulated gene expression. J Biol Chem 279(30):31304-31311. (Pubitemid 39037796)
23. Pfeffer LM, Mullersman JE, Pfeffer SR, Murti A, Shi W, Yang CH. 1997. STAT3 as an adapter to couple phosphatidylinositol-3 kinase to the IFNAR-1 chain of the type I IFN receptor. Science 276:1418-1420. (Pubitemid 27235410)
24. Ploegh HL. 2000. Immune and other responses to viral infections. Nutr Rev 58(2 Pt 2):S25-S30; discussion S63-S73 (Pubitemid 30165159)
25. Pomerantz JL, Baltimore D. 2002. Two pathways to NF-κB. Mol Cell 10(4):693-695.
26. Rani MR, Hibbert L, Sizemore N, Stark GR, Ransohoff RM. 2002. Requirement of phosphoinositide 3-kinase and Akt for interferon-beta-mediated induction of the beta-R1 (SCYB11) gene. J Biol Chem 277(41):38456-38461. (Pubitemid 35154703)
27. Rothe M, Sarma V, Dixit VM, Goeddel DV. 1995. TRAF2-mediated activation of NF-κ B by TNF receptor 2 and CD40. Science 269(5229):1424-1427.
28. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W. 2009. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 15(1):31-33.
29. Scagnolari C, Zingariello P, Vecchiet J, Selvaggi C, Racciatti D, Taliani G, Riva E, Pizzigallo E, Antonelli G. 2010. Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha. Virol J 7:311.
30. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-κ B signaling pathway. Science 293(5534):1495-1499. (Pubitemid 32801552)
31. Si ML, Zhu S, Wu H, Lu Z,Wu F, Mo YY. 2007. miR-21-mediated tumor growth. Oncogene 26(19):2799-2803. (Pubitemid 46663837)
32. Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, Maniatis T. 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315(5816):1274-1278. (Pubitemid 46364264)
33. Uddin S, Fish EN, Sher DA, Gardziola C, White MF, Platanias LC. 1997. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. J Immunol 158:2390-2397. (Pubitemid 127470026)
34. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. 1996. Suppression of TNF-a-induced apotosis by NF-κB. Science 274:787-789.
35. Vestal DJ, Jeyaratnam JA. 2011. The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase. J Interferon Cytokine Res 31(1):89-97.
36. Wang C-Y, Mayo MW, Baldwin AS Jr. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NFkB. Science 274:784-787. (Pubitemid 26398259)
37. Wei L, Sandbulte MR, Thomas PG, Webby RJ, Homayouni R, Pfeffer LM. 2006. NFkappaB negatively regulates interferoninduced gene expression and anti-influenza activity. J Biol Chem 281(17):11678-11684. (Pubitemid 43855425)
38. Yang CH, Murti A, Basu L, Kim JG, Pfeffer LM. 2000. IFNalpha/beta promotes cell survival by activating NF-κB. Proc Natl Acad Sci U S A 97:13631-13636.
39. Yang CH, Murti A, Pfeffer LM. 1998. STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities. Proc Natl Acad Sci U S A 95:5568-5572. (Pubitemid 28224135)
40. Yang CH, Murti A, Pfeffer LM. 2005a. IFN induces NIK/TRAF dependent NF-κB activation to promote cell survival. J Biol Chem 280(36):31530-31536.
41. Yang CH, Murti A, Pfeffer SR, Kim JG, Donner DB, Pfeffer LM. 2001. Interferonalpha/beta promotes cell survival by activating NF-κB through phosphatidylinositol-3 kinase and Akt. J Biol Chem 276:13756-13761.
42. Yang CH, Murti A, Valentine WJ, Du Z, Pfeffer LM. 2005b. Interferon alpha activates NF-κB in JAK1-deficient cells through a TYK2-dependent pathway. J Biol Chem 280(27): 25849-25853. (Pubitemid 40962295)
43. Yang CH, Wei L, Pfeffer SR, Du Z, Murti A, Valentine WJ, Zheng Y, Pfeffer LM. 2007. Identification of CXCL11 as a STAT3-dependent gene induced by IFN. J Immunol 178(2): 986-992. (Pubitemid 46095172)
44. Yang CH, Yue J, Fan M, Pfeffer LM. 2010. IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis. Cancer Res 70(20):8108-8116.